The complicated path to true causes of disease: role of nuclear factor B in inflammatory bowel disease

This publication has 11 references indexed in Scilit:

• Activation of nuclear factor B in colonic mucosa from patients with collagenous and ulcerative colitis
  Gut, 2005
• Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease
  Gut, 2004
• Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations
  The Lancet, 2001
• Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
  Nature, 2001
• A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
  Nature, 2001
• Nuclear factor κB is activated in macrophages and epithelial cells of inflamed intestinal mucosa
  Gastroenterology, 1998
• Activation of nuclear factor kappa B in inflammatory bowel disease
  Gut, 1998
• Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
  New England Journal of Medicine, 1997
• Local administration of antisense phosphorothiate olignucleotides to the p65 subunit of NF–κB abrogates established experimental colitis in mice
  Nature Medicine, 1996
• Tolerance to lipopolysaccharide involves mobilization of nuclear factor kappa B with predominance of p50 homodimers.
  Journal of Biological Chemistry, 1994